Inhalation is an obvious drug delivery method for lung diseases. Also for vaccines and other biological drugs, inhalation offers unique advantages for medical professionals - and patients get a pain-free and self-administrable delivery method.
Producing powders for inhalation is relatively easy on a small scale, but it can be hard to replicate at a commercial level. GEA Niro has however developed highly specialised spray drying nozzles that gives particle engineering capabilities, even at a large scale.
Using GEA Niro´s knowledge of spray drying and formulation makes it possible to accurately manipulate aerodynamic particle size and flow properties.
Consequently GEA Niro´s technology makes it easier than ever before to efficiently produce therapies in the form of free-flowing particles of a small aerodynamic size, suitable for inhalation. As a delivery method, inhalation is particularly relevant for commercialising biological compounds, e.g., hormones, peptides and proteins that risk degradation if ingested.